OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 13
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 13
Showing 13 citing articles:
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Targeting acquired resistance via promoting stemness of EGFR mutant mitigates lung adenocarcinomas progression: Intervention by harpagoside (Xuandanqingjin decoction)
Jiamao Lin, Lei Liu, Shenglin Ma, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106729-106729
Closed Access
Jiamao Lin, Lei Liu, Shenglin Ma, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106729-106729
Closed Access
JAK inhibitors as a promising therapy for immune-mediated photodermatoses
Mohammad Malekan, Saeid Taghiloo, Armaghan Kazeminejad, et al.
Drug Discovery Today (2025), pp. 104344-104344
Closed Access
Mohammad Malekan, Saeid Taghiloo, Armaghan Kazeminejad, et al.
Drug Discovery Today (2025), pp. 104344-104344
Closed Access
STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Natural Alkaloids Modulating Macrophage Polarization: Innovative Therapeutic Strategies for Inflammatory, Cardiovascular, and Cancerous Diseases
Jing Lü, Minghao Yin, Yixuan Song, et al.
Phytomedicine (2025), pp. 156709-156709
Closed Access
Jing Lü, Minghao Yin, Yixuan Song, et al.
Phytomedicine (2025), pp. 156709-156709
Closed Access
The pharmacological and therapeutic versatility of Allium species: a comprehensive exploration of bioactive constituents and biological activities
Neeta Singh, Anjali Gusain, Manisha Nigam, et al.
Deleted Journal (2025) Vol. 7, Iss. 4
Open Access
Neeta Singh, Anjali Gusain, Manisha Nigam, et al.
Deleted Journal (2025) Vol. 7, Iss. 4
Open Access
Role of signaling pathways in endometrial cancer
Nikita Balhara, Ritu Yadav, Meenakshi Chauhan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Nikita Balhara, Ritu Yadav, Meenakshi Chauhan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Interlinking pathways: a narrative review on the role of IL-6 in cancer and atherosclerosis
Riccardo Cau, Luca Saba
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 6, pp. 1186-1201
Open Access | Times Cited: 3
Riccardo Cau, Luca Saba
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 6, pp. 1186-1201
Open Access | Times Cited: 3
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy
Ludovica Lopresti, Vanessa Tatangelo, Cosima T. Baldari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Ludovica Lopresti, Vanessa Tatangelo, Cosima T. Baldari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Exploring the mechanism of Jianpi Lishi Jiedu Granules against postoperative recurrence of colorectal adenoma based on IL-6/JAK/STAT3 signaling pathway
Yuzhen Huang, Yulu Wang, Hao Wu, et al.
Cellular Signalling (2024), pp. 111535-111535
Closed Access | Times Cited: 1
Yuzhen Huang, Yulu Wang, Hao Wu, et al.
Cellular Signalling (2024), pp. 111535-111535
Closed Access | Times Cited: 1
Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer
Esther Rodman, Michael J. Emch, Xiaonan Hou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Esther Rodman, Michael J. Emch, Xiaonan Hou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dual-responsive natural killer cell nano-engagers for cancer immunotherapy via inhibiting IL-6/JAK2/STAT3 pathway
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Unraveling TRPV1’s Role in Cancer: Expression, Modulation, and Therapeutic Opportunities with Capsaicin
Subramanyam Reddy Chinreddy, Nicole Tendayi Mashozhera, Badraldeen Rashrash, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4729-4729
Open Access
Subramanyam Reddy Chinreddy, Nicole Tendayi Mashozhera, Badraldeen Rashrash, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4729-4729
Open Access
